InnovAge (INNV) director receives 8,539 RSU equity award, holds 76,696 shares

Rhea-AI Filing Summary

Kennedy Edward Moore Jr. reported acquisition or exercise transactions in this Form 4 filing.

InnovAge Holding Corp. director receives equity award

Director Edward Moore Kennedy Jr. was granted 8,539 Restricted Stock Units (RSUs) of InnovAge Holding Corp. common stock. These RSUs were awarded at no cash cost to him and increase his direct holdings to 76,696 shares.

The RSUs will be settled in shares of common stock and are scheduled to vest in full on June 30, 2027, as long as he continues to serve with the company. This filing reflects a compensation-related equity grant rather than an open-market stock purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kennedy Edward Moore Jr.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.001 par value	8,539	$0.00	--

Holdings After Transaction: Common Stock, $0.001 par value — 76,696 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs Granted: 8,539 units Grant Price: $0.0000 per share Holdings After Transaction: 76,696 shares +1 more

4 metrics

RSUs Granted 8,539 units Equity grant reported on Form 4

Grant Price $0.0000 per share RSU award price

Holdings After Transaction 76,696 shares Total direct InnovAge common stock after grant

Vesting Date June 30, 2027 RSUs vest in full on this date, subject to service

Key Terms

Restricted Stock Units ("RSUs"), vest in full, grant, award, or other acquisition

3 terms

Restricted Stock Units ("RSUs") financial

"Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vest in full financial

"will vest in full on June 30, 2027, subject to the Reporting Person's continued service"

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:33 PM Accepted by SEC EDGAR 07/02/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kennedy Edward Moore Jr.

(Last) (First) (Middle)

8950 E LOWRY BLVD

(Street)

DENVER COLORADO 80230

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
InnovAge Holding Corp. [ INNV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.001 par value	07/01/2026		A		8,539(1)	A	$0	76,696	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer.

Remarks:

	/s/ Nicole D'Amato, by Power of Attorney	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did InnovAge (INNV) director Edward Moore Kennedy Jr. report in this Form 4?

He reported receiving 8,539 Restricted Stock Units (RSUs) of InnovAge common stock as a grant. These RSUs are a compensation-related equity award, not an open-market trade, and will be settled in shares when they vest in the future.

How many InnovAge (INNV) shares does the director hold after this RSU grant?

After the RSU grant, Edward Moore Kennedy Jr. holds 76,696 shares of InnovAge common stock directly. This total includes the newly awarded 8,539 RSUs, which are scheduled to vest later, assuming continued service with the company.

When do the newly granted InnovAge (INNV) RSUs vest for the director?

The 8,539 Restricted Stock Units granted to Edward Moore Kennedy Jr. are scheduled to vest in full on June 30, 2027. Vesting is contingent on his continued service with InnovAge through that date, according to the filing’s footnote disclosure.

Were the InnovAge (INNV) RSUs granted to the director purchased on the open market?

No, the 8,539 RSUs were not purchased on the open market. They were granted at a price of $0.0000 per share as a compensation-related award, meaning no cash changed hands in connection with this acquisition.

What type of security did InnovAge (INNV) grant to its director in this transaction?

InnovAge granted Restricted Stock Units (RSUs) that will be settled in shares of common stock. These RSUs represent a right to receive InnovAge shares in the future, subject to vesting conditions, rather than immediate ownership of freely tradable stock.

Is this InnovAge (INNV) Form 4 transaction a buy or sell signal from the director?

The transaction is classified as an acquisition via grant or award, not an open-market buy or sell. It reflects routine equity compensation, where the director receives RSUs that vest over time, rather than an active trading decision in the market.